Literature DB >> 3891762

Immunocytochemical demonstration of tissue-type plasminogen activator in endocrine cells of the rat pituitary gland.

P Kristensen, L S Nielsen, J Grøndahl-Hansen, P B Andresen, L I Larsson, K Danø.   

Abstract

We immunocytochemically stained rat pituitary glands using antibodies against plasminogen activators of the tissue type (t-PA) and the urokinase type (u-PA). A large population of endocrine cells in the anterior lobe of the gland displayed intense cytoplasmic immunoreactivity with anti-t-PA. In some areas of the intermediate lobe we found a weak staining, and we observed weakly staining granular structures in the posterior lobe. Controls included absorption of the antibodies with highly purified t-PA. In addition, SDS PAGE followed by immunoblotting of pituitary gland extracts revealed only one band with an electrophoretic mobility similar to that of t-PA when stained with anti-t-PA IgG. No u-PA immunoreactivity was detected in the rat pituitary gland. Sequential staining experiments using antibodies against growth hormone and t-PA demonstrated that the t-PA-immunoreactive cells constitute a large subpopulation of the growth hormone-containing cells. These findings represent the first direct evidence for the presence of t-PA in cell types other than endothelial cells in the intact normal organism. In this article we discuss the implications of the results for a possible role of t-PA in the posttranslational processing of prohormones.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3891762      PMCID: PMC2113636          DOI: 10.1083/jcb.101.1.305

Source DB:  PubMed          Journal:  J Cell Biol        ISSN: 0021-9525            Impact factor:   10.539


  35 in total

1.  Follicular plasminogen and plasminogen activator and the effect of plasmin on ovarian follicle wall.

Authors:  W H Beers
Journal:  Cell       Date:  1975-11       Impact factor: 41.582

2.  An efficient method of antibody elution for the successive or simultaneous localization of two antigens by immunocytochemistry.

Authors:  G Tramu; A Pillez; J Leonardelli
Journal:  J Histochem Cytochem       Date:  1978-04       Impact factor: 2.479

3.  Macrophage plasminogen activator: modulation of enzyme production by anti-inflammatory steroids, mitotic inhibitors, and cyclic nucleotides.

Authors:  J D Vassalli; J Hamilton; E Reich
Journal:  Cell       Date:  1976-06       Impact factor: 41.582

4.  An enzymatic function associated with transformation of fibroblasts by oncogenic viruses. I. Chick embryo fibroblast cultures transformed by avian RNA tumor viruses.

Authors:  J C Unkeless; A Tobia; L Ossowski; J P Quigley; D B Rifkin; E Reich
Journal:  J Exp Med       Date:  1973-01-01       Impact factor: 14.307

5.  Plasminogen activator in early embryogenesis: enzyme production by trophoblast and parietal endoderm.

Authors:  S Strickland; E Reich; M I Sherman
Journal:  Cell       Date:  1976-10       Impact factor: 41.582

6.  The structure of the human tissue-type plasminogen activator gene: correlation of intron and exon structures to functional and structural domains.

Authors:  T Ny; F Elgh; B Lund
Journal:  Proc Natl Acad Sci U S A       Date:  1984-09       Impact factor: 11.205

7.  Human endothelial cells contain one type of plasminogen activator.

Authors:  P Kristensen; L I Larsson; L S Nielsen; J Grøndahl-Hansen; P A Andreasen; K Danø
Journal:  FEBS Lett       Date:  1984-03-12       Impact factor: 4.124

8.  Monoclonal antibody to human 66,000 molecular weight plasminogen activator from melanoma cells. Specific enzyme inhibition and one-step affinity purification.

Authors:  L S Nielsen; J G Hansen; P A Andreasen; L Skriver; K Danø; J Zeuthen
Journal:  EMBO J       Date:  1983       Impact factor: 11.598

9.  Inactive proenzyme to tissue-type plasminogen activator from human melanoma cells, identified after affinity purification with a monoclonal antibody.

Authors:  P A Andreasen; L S Nielsen; J Grøndahl-Hansen; L Skriver; J Zeuthen; R W Stephens; K Danø
Journal:  EMBO J       Date:  1984-01       Impact factor: 11.598

10.  A study of proteases and protease-inhibitor complexes in biological fluids.

Authors:  A Granelli-Piperno; E Reich
Journal:  J Exp Med       Date:  1978-07-01       Impact factor: 14.307

View more
  16 in total

1.  Tissue-type plasminogen activator in rat adrenal medulla.

Authors:  P Kristensen; D M Hougaard; L S Nielsen; K Danø
Journal:  Histochemistry       Date:  1986

2.  Immunohistological detection of Saruplase (recombinant single-chain urokinase-type plasminogen activator) in normal rat tissue.

Authors:  T Wöhrmann; T Matthiesen; H Beier; L Flohé
Journal:  Histochemistry       Date:  1991

3.  Fractionation of heparin by chromatography on a tissue plasminogen activator-Sepharose column.

Authors:  P Andrade-Gordon; S Strickland
Journal:  Proc Natl Acad Sci U S A       Date:  1990-03       Impact factor: 11.205

4.  Plasminogen activator inhibitor-type 1 in Lewis lung carcinoma.

Authors:  P Kristensen; C Pyke; L R Lund; P A Andreasen; K Danø
Journal:  Histochemistry       Date:  1990

5.  Murine lymphocytes with natural killer activity express CTL-derived serine protease genes.

Authors:  S K Anderson; K K Hong; D W Hoskin; W Abramow-Newerly; G M Fulop; R A Phillips; N Hozumi; J C Roder
Journal:  Immunology       Date:  1989-06       Impact factor: 7.397

6.  Urokinase- and tissue-type plasminogen activators are suppressed by cortisol in the involuting prostate of castrated rats.

Authors:  S N Freeman; P S Rennie; J Chao; L R Lund; P A Andreasen
Journal:  Biochem J       Date:  1990-07-01       Impact factor: 3.857

7.  Modulation of fibrinolysis by ionizing radiation.

Authors:  J S Rao; A Rayford; M Yamamoto; K K Ang; P Tofilon; R Sawaya
Journal:  J Neurooncol       Date:  1994       Impact factor: 4.130

8.  Tetranectin immunoreactivity in normal human tissues. An immunohistochemical study of exocrine epithelia and mesenchyme.

Authors:  L Christensen; I Clemmensen
Journal:  Histochemistry       Date:  1989

9.  Plasminogen activator inhibitor (type-1) in rat adrenal medulla.

Authors:  J Eriksen; P Kristensen; C Pyke; K Danø
Journal:  Histochemistry       Date:  1989

10.  Expression of a cytomegalovirus IE-1-factor VIII cDNA hybrid gene in transgenic mice.

Authors:  T R Mikkelsen; B Chapman; N Din; J Ingerslev; P Kristensen; K Poulsen; J P Hjorth
Journal:  Transgenic Res       Date:  1992-07       Impact factor: 2.788

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.